سعر ميديهيالو كريم 30 جم 2025

Topical cream combining silver sulfadiazine (sulfonamide antibacterial) with sodium hyaluronate, 30 g tube; Debeiky / Zeta Pharma, Egypt.

• Prophylaxis and treatment of infected skin lesions: wounds, ulcers, abrasions and burns of any degree (manufacturer statement).Zeta Pharma (manufacturer website)
• Adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns (silver sulfadiazine 1% cream).DailyMed (U.S. National Library of Medicine)

• Transient leukopenia (mainly decreased neutrophil count) has been reported with silver sulfadiazine.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to silver sulfadiazine or any other ingredient of the preparation.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Because sulfonamides increase the possibility of kernicterus, silver sulfadiazine should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Potential cross-sensitivity between silver sulfadiazine and other sulfonamides; reactions attributed to sulfonamides may occur.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Use in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals may be hazardous, as haemolysis may occur.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• CimetidineAn increased incidence of leukopenia has been reported in patients treated concurrently with cimetidine.DailyMed (U.S. National Library of Medicine)

• It is not known whether silver sulfadiazine is excreted in human milk; because of possible serious sulfonamide reactions in nursing infants, decide whether to discontinue nursing or the drug.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

English text not available for this section.